"Risks" Of Self-Medication

31 October 1997

Americans are putting themselves at risk through overenthusiastic use ofself-medication drug products, says a survey conducted for the American Pharmaceutical Association and Prevention magazine.

It found that eight out of 10 adults treat themselves before calling on a doctor or other health care professional for headaches (80%), upset stomachs (76%), coughs and colds (73%) and fevers (71%). A third said they exceeded recommended doses "because they felt they needed to," to treat their condition effectively.

By their own admission, people may not always self-medicate appropriately, said Lucinda Maine, APhA senior vice president for professional affairs. This "can have serious health consequences," and the growing availability of nonprescription products means that now, more than ever, consumers need advice, she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight